VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 398 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | – | 0 | – | 0.00% | – |
Q2 2019 | $0 | – | 0 | – | 0.00% | – |
Q1 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $230,000 | -41.2% | 10,902 | -48.3% | 1.03% | +4.0% |
Q3 2018 | $391,000 | +6.8% | 21,086 | +28.6% | 0.99% | -50.5% |
Q2 2018 | $366,000 | -24.1% | 16,398 | -21.0% | 1.99% | +204.1% |
Q4 2017 | $482,000 | +41.3% | 20,746 | +39.8% | 0.66% | +16.3% |
Q3 2017 | $341,000 | -29.8% | 14,840 | -32.5% | 0.56% | -42.6% |
Q2 2017 | $486,000 | -87.8% | 21,997 | -87.4% | 0.98% | -82.2% |
Q1 2017 | $3,985,000 | -39.6% | 174,687 | -44.6% | 5.50% | -30.5% |
Q4 2016 | $6,602,000 | -19.8% | 315,577 | +1.3% | 7.91% | +32.8% |
Q3 2016 | $8,231,000 | – | 311,440 | – | 5.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |